VAERS Explorer
Back to explore

Report #2844594

Received Jun 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
MI
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNK——

Symptoms (1)

Influenza like illness

Symptom narrative

FBE reported AE on behalf of HCP who reported on behalf of themselves that they experienced flu-like symptoms within 48 hours of being administered CAPVAXIVE. Additional patient demographics unknown. No additional AE details reported. FBE was made aw; This spontaneous report was received from an Other health professional and refers to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), (dose, lot # and expiration date were not reported). On an unknown date, the patient experienced flu-like symptoms within 48 hours of being administered CAPVAXIVE. At the reporting time, the outcome of the event was unknown. The action taken with Pneumococcal 21-valent Conjugate Vaccine was reported as not applicable. The causal relationship between the event of and Pneumococcal 21-valent Conjugate Vaccine was unknown/not reported/not provided.